By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic Technologies announced today it has reached an agreement with AutoImmun Diagnostika to settle a dispute over the German firm's use of GTG's non-coding DNA technology.

As a result, GTG has granted non-exclusive rights to AutoImmun covering several of its patents. Further details of the licensing agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."